We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-5.2%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
-$395M
(-10%)
Cap. Flow
+$563M
Cap. Flow
% of AUM
15.85%
Top 10 Holdings %
Top 10 Hldgs %
43.38%
Holding
114
New
26
Increased
23
Reduced
23
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$187M |
| 2 |
Pfizer
PFE
|
+$168M |
| 3 |
Gilead Sciences
GILD
|
+$125M |
| 4 |
UnitedHealth
UNH
|
+$125M |
| 5 |
Eli Lilly
LLY
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$84.3M |
| 2 |
Apple
AAPL
|
+$80.7M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$75.5M |
| 4 |
Liberty Global Class C
LBTYK
|
+$74M |
| 5 |
VMW
VMware, Inc
VMW
|
+$72.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.47% |
| 2 | Communication Services | 6.34% |
| 3 | Financials | 5.66% |
| 4 | Technology | 4.95% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Tenet Healthcare
THC
$21.8B
| – | – |
-1,156,814
| Closed | -$67M |
|
|
VMW
102
DELISTED
VMware, Inc
VMW
| – | – |
-841,721
| Closed | -$72.2M |
|
|
SIOX
103
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – |
-119,093
| Closed | -$19.4M |
|
|
VAR
104
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-417,302
| Closed | -$30.9M |
|
|
ONCE
105
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-77,141
| Closed | -$4.65M |
|
|
MSCC
106
DELISTED
Microsemi Corp
MSCC
| – | – |
-59,711
| Closed | -$2.09M |
|
|
EXAR
107
DELISTED
Exar Corporation
EXAR
| – | – |
-54,263
| Closed | -$531K |
|
|
ISIL
108
DELISTED
Intersil Corp
ISIL
| – | – |
-132,060
| Closed | -$1.65M |
|
|
PGND
109
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| – | – |
-233,662
| Closed | -$6.7M |
|
|
ATML
110
DELISTED
ATMEL CORP
ATML
| – | – |
-1,025,467
| Closed | -$10.1M |
|
|
ZSPH
111
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| – | – |
-451,071
| Closed | -$23.6M |
|
|
OREX
112
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-527,867
| Closed | -$26.1M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
AC
PFM Health Sciences's Q3 2015 Portfolio in Review
As of Q3 2015, PFM Health Sciences held 114 positions worth $3.55B, down 10% from $3.95B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
PFM Health Sciences deployed $563M of net new capital in Q3 2015, opening 26 new positions and adding to 23 existing holdings. Its largest new stake was Allergan plc: 608,789 shares worth $165M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 48% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was BROADCOM CORP CL-A, an estimated $75.5M trimmed.
- PFM Health Sciences's largest Q3 2015 buy was Allergan plc: 608,789 shares worth $165M.
- PFM Health Sciences added most to Pfizer in Q3 2015, an estimated $168M increase.
- PFM Health Sciences's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $75.5M.
- PFM Health Sciences fully exited Elevance Health in Q3 2015, selling an estimated $84.3M.
- PFM Health Sciences's ten largest holdings make up 43% of its $3.55B portfolio in Q3 2015.
- PFM Health Sciences opened 26 new positions and closed 40 in Q3 2015.
- PFM Health Sciences's portfolio value fell 10% quarter-over-quarter to $3.55B.
Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.